Patents by Inventor Eldar Kim

Eldar Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-CXCR4 ANTIBODIES
    Publication number: 20190389958
    Abstract: The present invention relates to monospecific antibodies against CXCR4 or binding fragments thereof, to the use of such anti-CXCR4 antibodies or binding fragments in treating diseases whose pathogenesis is related to activation of CXCR4, as well as to pharmaceutical compositions comprising such anti-CXCR4 antibodies or binding fragments.
    Type: Application
    Filed: January 31, 2017
    Publication date: December 26, 2019
    Applicant: MSM Protein Technologies, Inc.
    Inventors: Andres McAllister, Corinne Moulton, Colleen Stauffer-Kelleher, Svetlana Abbasova, Viktoriia Vasilyeva, Olga Rimkevich, Andrey Ulitin, Roman Mikhaylov, Tajib Mirzabekov, David Kreimer, Eldar Kim
  • Human Monoclonal Antibodies Against Human Chemokine Receptor CCR7
    Publication number: 20150344580
    Abstract: Aspects of this invention include fully human antibodies or fragments thereof that bind specifically to human CCR7 receptor. Such antibodies or fragments thereof can be used to treat disorders involving over function of the CCR7 receptor, including cancers. Other uses include detection of human CCR7 receptor in biological samples for diagnostic or evaluative purposes. Fully human antibodies against human CCR7 therefore can be used to diagnose disorders involving CCR7. Further, antibodies of this invention can be useful for treating disorders involving CCR7 by inhibiting binding of native chemokines to the CCR7, and thereby decrease effects of those chemokines. Anti-CCR7 antibodies of this invention can also be used as specific targeting agents to bring toxic agents to CCR7-expressing cells, to inhibit chemotaxis, and therefore can be effective therapeutic agents.
    Type: Application
    Filed: March 13, 2013
    Publication date: December 3, 2015
    Inventors: Svetlana Abbasova, Viktoriia Vasilyeva, Andrey Ulitin, Olga Rimkevich, Valery Solovyev, Tajib Mirzabeko, Roman Mikhaylov, David Kreimer, Eldar Kim
  • HUMAN MONOCLONAL ANTIBODIES AGAINST HUMAN CHEMOKINE RECEPTOR CCR6
    Publication number: 20150337037
    Abstract: Aspects of this invention include fully human antibodies or fragments thereof that bind specifically to human CCR6 receptor. Such antibodies or fragments thereof can be used to treat disorders involving over function of the CCR6 receptor, including cancers, inflammatory diseases and fibrotic diseases. Other uses include detection of human CCR6 receptor in biological samples for diagnostic or evaluative purposes.
    Type: Application
    Filed: March 14, 2013
    Publication date: November 26, 2015
    Applicant: MSM Protein Technologies
    Inventors: Eldar Kim, Viktoriia S. Vasilyeva, Svetlana Abbasova, Ekaterina Ivanova, Elena Ovchinnikova, Andre Ulitin, Roman Mikhaylov